1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growth of Bioreactors in Pharmaceuticals
4.2.2 Technological Advancements in Bioreactors
4.2.3 Adoption of Single-use bioreactors (SUBs) and Hybrid Bioreactors
4.3 Market Restraints
4.3.1 Concerns Regarding the Use of Single-use Bioreactors (SUBs)
4.3.2 Limited Storage Capacity
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Glass
5.1.2 Stainless Steel
5.1.3 Single-use
5.2 By Usage
5.2.1 Lab-scale Production
5.2.2 Pilot-scale Production
5.2.3 Full-scale Production
5.3 By Scale
5.3.1 5L-20L
5.3.2 20L-200L
5.3.3 200L-1,500L
5.3.4 Above 1,500L
5.4 By Control Type
5.4.1 Manual
5.4.2 Automated (MFCs)
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 GE Healthcare
6.1.2 Merck KGaA
6.1.3 Eppendorf AG
6.1.4 Sartorius AG
6.1.5 Pall Corporation (Danaher Corporation)
6.1.6 Getinge AB
6.1.7 Bioengineering AG
6.1.8 Infors HT
6.1.9 Solida Biotech GmBH
6.1.10 Solaris Biotech
6.1.11 Thermo Fisher Scientific Inc.
6.1.12 Esco Lifesciences Group Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS